Successful Treatment Of Patients With Hcv Gt3 Infection And Cirrhosis With Elbasvir/Grazoprevir Plus Sofosbuvir Does Not Correct Insulin Resistance By 12 Weeks Post-Treatment

JOURNAL OF HEPATOLOGY(2017)

引用 0|浏览41
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要